Original Source(s)
Related Content
FDA Cleared ≠ FDA Validated
Most AI medical devices reach the market without independent evidence of safety or effectiveness.
by Kerri Miller
May 4, 2026
-
2 min
FDA Approves New First-Line TNBC Regimen
Phase 3 results showed longer progression-free survival with pembrolizumab plus sacituzumab govitecan-hziy than with pembrolizumab plus chemotherapy in previously untreated PD-L1-positive advanced triple-negative breast cancer.
June 26, 2026
-
3 min
Mandatory Training Modules Deserve a Harder Look
A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.
by Kerri Miller
April 16, 2026
-
3 min
